Skip to content
Screener

Indivior Pharmaceuticals, Inc. INDV Asset turnover

Asset turnover at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
0.4×-0.1×
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
0.4×-0.1×
Alkermes logo
AlkermesALKS
0.5×-0.2×
Emergent Biosolutions logo
Emergent BiosolutionsEBS
0.6×0.0×

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.56B+64.7%
Enterprise value$4.9B+86.4%
P/E18.2×-7.5×
P/S3.5×+1.2×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Return on equity-117%—
Debt / equity-3.5×—
Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.

total revenue/total assets=1×

Based on trailing twelve months.

The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →

Filed
Apr 30, 2026, 4:02 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028850

FAQ

What is Indivior Pharmaceuticals, Inc.'s asset turnover?
Indivior Pharmaceuticals, Inc. (INDV) reported asset turnover of 1× in Q1 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Indivior Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude